EW INVESTOR UPDATE: Did Edwards Lifesciences Mislead Investors Causing Losses? Contact BFA Law about the Pending Securities Fraud Lawsuit ( NYSE:EW ) - Edwards Lifesciences ( NYSE:EW )
NEW YORK, Nov. 10, 2024 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation EW and certain of the Company's senior executives for potential violations of the federal securities laws.
| Ticker |
Sentiment |
Impact |
|
EW
|
Somewhat Bullish
|
45 %
|
|
TSLA
|
Somewhat Bullish
|
7 %
|
